Clinical efficacy is equivalent
Since obesity, insulin resistance, liver fat, and metabolic dysfunction are closely linked, GLP-1 and glucagon-based combinations are being studied for their potential to reduce liver fat, improve metabolic markers, and slow disease progression
Creating a bedtime routine and a clear sleep schedule makes all the difference, so its worth sitting down and thinking about what that looks like for you
The reasons are multifactorial: chronic inflammation damages blood vessel walls, corticosteroid use raises cholesterol and blood pressure, lupus-specific antibodies (particularly antiphospholipid antibodies) increase clotting risk, and the metabolic disruption caused by both the disease and its treatments creates a perfect storm for atherosclerosis
Dapagliflozin attenuates heart failure with preserved ejection fraction remodeling and dysfunction by elevating -hydroxybutyrate-activated citrate synthase
Ensure the medication is clear and free from particles or discoloration
